[Ip-health] MSF initial reaction to Novartis v India Supreme Court case

Joanna Keenan-Siciliano joanna.l.keenan at gmail.com
Mon Apr 1 00:46:37 PDT 2013


With the ruling of the Supreme Court in the Novartis case been issued this
morning, Medecins Sans Frontieres has released the below initial reaction:


"Although MSF has yet to see the text of the verdict, this appears to be
the best outcome for patients in developing countries as fewer patents will
be granted on existing medicines. Novartis's attacks on the elements of
India's patent law that protect public health have failed.  The Supreme
Court's decision prevents companies from abusing the patent system to get
unwarranted patents on existing medicines, to block price-busting generic
competition on HIV and other essential medicines. This confirms that all
patent offices in India have to use this interpretation and the law is now
clear and must be strictly applied."
 - Leena Menghaney, Médecins Sans Frontières Access Campaign Manager, India.


Many thanks

Joanna Keenan
Press Officer
Médecins Sans Frontières - Access Campaign
P: +41 22 849 87 45
M: +41 79 203 13 02
E: joanna.keenan[at]geneva.msf.org
T: twitter.com/joanna_keenan

msfaccess.org
twitter.com/MSF_access
facebook.com/MSFaccess



More information about the Ip-health mailing list